May 15, 2023
University of Cincinnati’s Melanie Thomas-Castillo, PsyD, and Stephen Rush, MD, recently published commentary on how psychiatrists can work to create a supportive environment for transgender and gender diverse patients in the journal Current Psychiatry.
October 25, 2023
The University of Cincinnati's Kate Chard and former Cincinnati Police Department sergeant Dave Corlett spoke with WCPO about their work to prevent veteran suicides through training tied to workplace stress and PTSD in law enforcement and the veteran community.
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
September 16, 2021
UC researchers are leading a pilot study examining how art therapy delivered through an app and pet robots can affect the mood of patients with hearing loss. The collaborative study seeks to allow patients to take their health into their own hands and increase accessibility of interventions.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
October 16, 2023
A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.
March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.
April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.